Calcium signaling and the therapeutic targeting of cancer cells
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
The calcium signal is implicated in a variety of processes important in tumor progression (e.g. proliferation and invasiveness). The calcium signal has also been shown to be important in other processes important in cancer progression including the development of resistance to current cancer therapies. In this review, we discuss how Ca2+ channels, pumps and exchangers may be drug targets in some cancer types. We consider what factors should be taken into account when considering an optimal Ca2+ channel, pump or exchanger as a candidate for further assessment as a novel drug target in cancer. We also present and summarize how some therapies for the treatment of cancer intersect with Ca2+ signaling and how pharmacological manipulation of the machinery of Ca2+ signaling could promote the effectiveness of some therapies. We also review new therapeutic opportunities for Ca2+ signal modulators in the context of the tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Clapham, D. E. (2007) · Cell · doi:10.1016/j.cell.2007.11.028 · Cited by 4,175
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Pre-metastatic niches: organ-specific homes for metastases
Peinado, H., Zhang, H., Matei, I. R., Costa-Silva, B., Hoshino, A., Rodrigues, G., Psaila, B., Kaplan, R. N., Bromberg, J. F., Kang, Y., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.6 · Cited by 1,889
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
Orai1 and STIM1 Are Critical for Breast Tumor Cell Migration and Metastasis
Yang, S., Zhang, J. J., & Huang, X.-Y. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.019 · Cited by 742
Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival
Roderick, H. L., & Cook, S. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2374 · Cited by 731
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Chen, J., Yao, Y., Gong, C., Yu, F., Su, S., Chen, J., Liu, B., Deng, H., Wang, F., Lin, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.006 · Cited by 641
The calcium–cancer signalling nexus
Monteith, G. R., Prevarskaya, N., & Roberts-Thomson, S. J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.18 · Cited by 635
Self-citationCalcium in tumour metastasis: new roles for known actors
Prevarskaya, N., Skryma, R., & Shuba, Y. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3105 · Cited by 605
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
The AM and FM of calcium signalling
Berridge, M. J. (1997) · Nature · doi:10.1038/386759a0 · Cited by 468
Enjoy the Trip: Calcium in Mitochondria Back and Forth
De Stefani, D., Rizzuto, R., & Pozzan, T. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034216 · Cited by 423
Unravelling biology and shifting paradigms in cancer with single-cell sequencing
Baslan, T., & Hicks, J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.58 · Cited by 381
Targeting EMT in cancer: opportunities for pharmacological intervention
Davis, F. M., Stewart, T. A., Thompson, E. W., & Monteith, G. R. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.06.006 · Cited by 361
Self-citationDavis, F. M., Azimi, I., Faville, R. A., Peters, A. A., Jalink, K., Putney, J. W., Goodhill, G. J., Thompson, E. W., Roberts-Thomson, S. J., & Monteith, G. R. (2014) · Oncogene · doi:10.1038/onc.2013.187 · Cited by 333
Self-citationZhang, L., & Barritt, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2146 · Cited by 316
Store-Independent Activation of Orai1 by SPCA2 in Mammary Tumors
Feng, M., Grice, D. M., Faddy, H. M., Nguyen, N., Leitch, S., Wang, Y., Muend, S., Kenny, P. A., Sukumar, S., Roberts-Thomson, S. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.08.040 · Cited by 306
Self-citationp53 at the endoplasmic reticulum regulates apoptosis in a Ca 2+ -dependent manner
Giorgi, C., Bonora, M., Sorrentino, G., Missiroli, S., Poletti, F., Suski, J. M., Galindo Ramirez, F., Rizzuto, R., Di Virgilio, F., Zito, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410723112 · Cited by 306
Wheeler, D. G., Groth, R. D., Ma, H., Barrett, C. F., Owen, S. F., Safa, P., & Tsien, R. W. (2012) · Cell · doi:10.1016/j.cell.2012.03.041 · Cited by 286
The mitochondrial calcium uniporter regulates breast cancer progression via HIF ‐1α
Tosatto, A., Sommaggio, R., Kummerow, C., Bentham, R. B., Blacker, T. S., Berecz, T., Duchen, M. R., Rosato, A., Bogeski, I., Szabadkai, G., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606255 · Cited by 258
PTEN Counteracts FBXL2 to Promote IP3R3- and Ca2+-Mediated Apoptosis Limiting Tumour Growth
Kuchay, S., Giorgi, C., Simoneschi, D., Pagan, J., Missiroli, S., Saraf, A., Florens, L., Washburn, M. P., Collazo-Lorduy, A., Castillo-Martin, M., et al. (2017) · Nature · doi:10.1038/nature22965 · Cited by 251
Nabissi, M., Morelli, M. B., Santoni, M., & Santoni, G. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs328 · Cited by 248
Cárdenas, C., Müller, M., McNeal, A., Lovy, A., Jaňa, F., Bustos, G., Urra, F., Smith, N., Molgó, J., Diehl, J. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.030 · Cited by 247
TRPV6 channel controls prostate cancer cell proliferation via Ca2+/NFAT-dependent pathways
Lehen'Kyi, V, Flourakis, M., Skryma, R., & Prevarskaya, N. (2007) · Oncogene · doi:10.1038/sj.onc.1210545 · Cited by 245
Direct Therapeutic Applications of Calcium Electroporation to Effectively Induce Tumor Necrosis
Frandsen, S. K., Gissel, H., Hojman, P., Tramm, T., Eriksen, J., & Gehl, J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3782 · Cited by 239
Remodelling of Ca2+transport in cancer: how it contributes to cancer hallmarks?
Prevarskaya, N., Ouadid-Ahidouch, H., Skryma, R., & Shuba, Y. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0097 · Cited by 236
Targeting the tumor microenvironment
Kenny, P. (2007) · Frontiers in Bioscience · doi:10.2741/2327 · Cited by 220
Emerging perspectives in store-operated Ca2+ entry: Roles of Orai, Stim and TRP
Smyth, J. T., DeHaven, W. I., Jones, B. F., Mercer, J. C., Trebak, M., Vazquez, G., & Putney, J. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.050 · Cited by 214
ORAI1-Mediated Calcium Influx in Lactation and in Breast Cancer
McAndrew, D., Grice, D. M., Peters, A. A., Davis, F. M., Stewart, T., Rice, M., Smart, C. E., Brown, M. A., Kenny, P. A., Roberts-Thomson, S. J., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0923 · Cited by 209
Self-citationLandowski, T. H., Megli, C. J., Nullmeyer, K. D., Lynch, R. M., & Dorr, R. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3684 · Cited by 202
Faouzi, M., Hague, F., Potier, M., Ahidouch, A., Sevestre, H., & Ouadid‐Ahidouch, H. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22363 · Cited by 200
Fiorio Pla, A., Ong, H. L., Cheng, K. T., Brossa, A., Bussolati, B., Lockwich, T., Paria, B., Munaron, L., & Ambudkar, I. S. (2012) · Oncogene · doi:10.1038/onc.2011.231 · Cited by 183
Ma, X., Chen, Z., Hua, D., He, D., Wang, L., Zhang, P., Wang, J., Cai, Y., Gao, C., Zhang, X., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400272111 · Cited by 180
Ma, X., Cai, Y., He, D., Zou, C., Zhang, P., Lo, C. Y., Xu, Z., Chan, F. L., Yu, S., Chen, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202989109 · Cited by 179
Schwarz, E. C., Qu, B., & Hoth, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.11.016 · Cited by 174
MICU1 drives glycolysis and chemoresistance in ovarian cancer
Chakraborty, P. K., Mustafi, S. B., Xiong, X., Dwivedi, S. K. D., Nesin, V., Saha, S., Zhang, M., Dhanasekaran, D., Jayaraman, M., Mannel, R., et al. (2017) · Nature Communications · doi:10.1038/ncomms14634 · Cited by 169
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
Lu, H., Chen, I., Shimoda, L. A., Park, Y., Zhang, C., Tran, L., Zhang, H., & Semenza, G. L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.001 · Cited by 168
Mahalingam, D., Wilding, G., Denmeade, S. R., Sarantopoulas, J., Cosgrove, D., Cetnar, J. P., Azad, N. S., Bruce, J. Y., Kurman, M. R., Allgood, V., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.72 · Cited by 168
Bcl-2 proteins and calcium signaling: complexity beneath the surface
Vervliet, T., Parys, J. B., & Bultynck, G. (2016) · Oncogene · doi:10.1038/onc.2016.31 · Cited by 166
Miranda, F., Mannion, D., Liu, S., Zheng, Y., Mangala, L. S., Redondo, C., Herrero-Gonzalez, S., Xu, R., Taylor, C., Chedom, D. F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.020 · Cited by 164
Role of TRP ion channels in cancer and tumorigenesis
Shapovalov, G., Ritaine, A., Skryma, R. N., & Prevarskaya, N. B. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-015-0525-1 · Cited by 159
Guen, V. J., Chavarria, T. E., Kröger, C., Ye, X., Weinberg, R. A., & Lees, J. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711534114 · Cited by 156
Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma
Kondratska, K., Kondratskyi, A., Yassine, M., Lemonnier, L., Lepage, G., Morabito, A., Skryma, R. N., & Prevarskaya, N. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.02.012 · Cited by 154
Adapala, R. K., Thoppil, R. J., Ghosh, K., Cappelli, H. C., Dudley, A. C., Paruchuri, S., Keshamouni, V, Klagsbrun, M., Meszaros, J. G., Chilian, W. M., et al. (2016) · Oncogene · doi:10.1038/onc.2015.83 · Cited by 153
Transient receptor potential channel C3 contributes to the progression of human ovarian cancer
Yang, S., Cao, Q., Zhou, K., Feng, Y. J., & Wang, Y. Z. (2009) · Oncogene · doi:10.1038/onc.2008.475 · Cited by 149
Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer
Roti, G., Carlton, A. L., Ross, K. N., Markstein, M., Pajcini, K. V., Su, A. H., Perrimon, N., Pear, W. S., Kung, A. L., Blacklow, S. C., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.015 · Cited by 149
Fu, S., Hirte, H. W., Welch, S. A., Ilenchuk, T. T., Lutes, T., Rice, C., Fields, N., Nemet, A., Dugourd, D., Piha-Paul, S. A., et al. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0438-z · Cited by 140
Raphaël, M., Lehen’kyi, V., Vandenberghe, M., Beck, B., Khalimonchyk, S., Abeele, F. V., Farsetti, L., Germain, E., Bokhobza, A., Mihalache, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413409111 · Cited by 136
Distinct Spatial Ca2+ Signatures Selectively Activate Different NFAT Transcription Factor Isoforms
Kar, P., & Parekh, A. B. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.027 · Cited by 133
Targetable T-type Calcium Channels Drive Glioblastoma
Zhang, Y., Cruickshanks, N. A., Yuan, F., Wang, B., Pahuski, M., Wulfkuhle, J. D., Gallagher, R. I., Koeppel, A. F., Hatef, S., Papanicolas, C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2347 · Cited by 132
Saunus, J. M., Quinn, M. C. J., Patch, A., Pearson, J. V., Bailey, P. J., Nones, K., Reed, A. E. M., Miller, D. K., Wilson, P. J., Al‐Ejeh, F., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4583 · Cited by 130
Calcium entry via ORAI1 regulates glioblastoma cell proliferation and apoptosis
Liu, H., Hughes, J. D., Rollins, S., Chen, B., & Perkins, E. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.09.005 · Cited by 129
Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor–Negative Breast Cancer
Peters, A. A., Simpson, P. T., Bassett, J. J., Lee, J. M., Da Silva, L., Reid, L. E., Song, S., Parat, M.-O., Lakhani, S. R., Kenny, P. A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0965 · Cited by 126
Self-citationThe role of the TRPV6 channel in cancer
Lehen’kyi, V., Raphaël, M., & Prevarskaya, N. B. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.225862 · Cited by 126
Lee, W. H., Choong, L. Y., Jin, T. H., Mon, N. N., Chong, S., Liew, C. S., Putti, T., Lu, S. Y., Harteneck, C., & Lim, Y. P. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.39 · Cited by 121
Bergmeier, W., Weidinger, C., Zee, I., & Feske, S. (2013) · Channels · doi:10.4161/chan.24302 · Cited by 121
Zhu, S., Zhou, H.-Y., Deng, S., Deng, S.-J., He, C., Li, X., Chen, J., Jin, Y., Hu, Z., Wang, F., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.189 · Cited by 120
Store-Operated Crac Channel Inhibitors: Opportunities and Challenges
Tian, C., Du, L., Zhou, Y., & Li, M. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0024 · Cited by 119
Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent
Wen, L., Liang, C., Chen, E., Chen, W., Liang, F., Zhi, X., Wei, T., Xue, F., Li, G., Yang, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep23269 · Cited by 115
Kang, S., Hong, J., Lee, J. M., Moon, H. E., Jeon, B., Choi, J., Yoon, N. A., Paek, S. H., Roh, E. J., Lee, C. J., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0169-t · Cited by 115
Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection
Hasna, J., Hague, F., Rodat‐Despoix, L., Geerts, D., Leroy, C., Tulasne, D., Ouadid‐Ahidouch, H., & Kischel, P. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-017-0007-1 · Cited by 114
TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway
Zhang, P., Liu, X., Li, H., Chen, Z., Yao, X., Jin, J., & Ma, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-03230-w · Cited by 111
Azimi, I., Milevskiy, M. J. G., Kaemmerer, E., Turner, D., Yapa, K. T. D. S., Brown, M. A., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2017) · Journal of Cell Science · doi:10.1242/jcs.196659 · Cited by 108
Self-citationWang, T., Chen, Z., Zhu, Y., Pan, Q., Liu, Y., Qi, X., Jin, L., Jin, J., Ma, X., & Hua, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.590364 · Cited by 104
Schmidt, S., Liu, G., Liu, G., Yang, W., Honisch, S., Pantelakos, S., Stournaras, C., Hönig, A., & Lang, F. J. W. (2014) · Oncotarget · doi:10.18632/oncotarget.2035 · Cited by 102
Davis, P. B., Yasothan, U., & Kirkpatrick, P. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3723 · Cited by 93
Giorgi, C., Bonora, M., Missiroli, S., Poletti, F., Ramirez, F. G., Morciano, G., Morganti, C., Pandolfi, P. P., Mammano, F., & Pinton, P. (2015) · Oncotarget · doi:10.18632/oncotarget.2935 · Cited by 93
Wang, T., Ning, K., Lu, T., Sun, X., Jin, L., Qi, X., Jin, J., & Hua, D. (2016) · Cancer Science · doi:10.1111/cas.13150 · Cited by 92
A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity
Zhou, X. Q., Friedmann, K. S., Lyrmann, H., Zhou, Y., Schoppmeyer, R., Knörck, A., Mang, S., Hoxha, C., Angenendt, A., Backes, C. S., et al. (2018) · The Journal of Physiology · doi:10.1113/jp274964 · Cited by 89
Shi, Y. Q., Ding, X., He, Z., Zhou, K.-C., Wang, Q., & Wang, Y.-Z. (2009) · Gut · doi:10.1136/gut.2009.181735 · Cited by 89
Tang, B., Xia, X., Lv, X., Yu, B., Yuan, J., Mai, X., Shang, J., Zhou, J., Liang, S., & Pang, R. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13029 · Cited by 89
Jeong, J., VanHouten, J. N., Dann, P. R., Kim, W., Sullivan, C. A. W., Yu, H., Liotta, L. A., Espina, V. A., Stern, D. F., Friedman, P. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516138113 · Cited by 86
Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells
Peters, A. A., Jamaludin, S. Y. N., Yapa, K. T. D. S., Chalmers, S., Wiegmans, A. P., Lim, H. F., Milevskiy, M. J. G., Azimi, I., Davis, F. M., Northwood, K. S., et al. (2017) · Oncogene · doi:10.1038/onc.2017.234 · Cited by 85
Self-citationNormal and Malignant Cells Exhibit Differential Responses to Calcium Electroporation
Frandsen, S. K., Krüger, M. B., Mangalanathan, U. M., Tramm, T., Mahmood, F., Novak, I., & Gehl, J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1611 · Cited by 84
Shepard, H. M., Jin, P., Slamon, D. J., Pirot, Z., & Maneval, D. C. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-73259-4_9 · Cited by 83
Ay, A., Benzerdjerb, N., Sevestre, H., Ahidouch, A., & Ouadid‐Ahidouch, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072889 · Cited by 82
Transmembrane helix connectivity in Orai1 controls two gates for calcium-dependent transcription
Frischauf, I., Litviňuková, M., Schober, R., Zayats, V., Svobodová, B., Bonhenry, D., Lunz, V., Cappello, S., Tociu, L., Řeha, D., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aao0358 · Cited by 81
Curry, M., Luk, N. A., Kenny, P. A., Roberts‐Thomson, S. J., & Monteith, G. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364737 · Cited by 80
Self-citationTauber, P., Aichinger, B., Christ, C. B., Stindl, J., Rhayem, Y., Beuschlein, F., Warth, R., & Bandulik, S. (2016) · Endocrinology · doi:10.1210/en.2015-2029 · Cited by 75
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin
Dziegielewska, B., Casarez, E. V., Yang, W. Z., Gray, L. S., Dziegielewski, J., & Slack‐Davis, J. K. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0456 · Cited by 74
Targeting Ca2+transport in cancer: close reality or long perspective?
Prevarskaya, N. B., Skryma, R. N., & Шуба, Я. М. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.741594 · Cited by 69
Peters, A. A., Milevskiy, M. J. G., Lee, W. C., Curry, M., Smart, C. E., Saunus, J. M., Reid, L., Silva, L. M. D., Marcial, D. L., Dray, E. V., et al. (2016) · Scientific Reports · doi:10.1038/srep25505 · Cited by 67
Self-citationDong, Y., Pan, Q., Li, J., Chen, Z., Zhang, F.-F., Liu, Y., Xing, H., Shi, M., Li, J., Li, X., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.076 · Cited by 65
Can, G., Akpinar, B., Baran, Y., Zhivotovsky, B., & Olsson, M. (2012) · Oncogene · doi:10.1038/onc.2012.467 · Cited by 65
Dziegielewska, B., Brautigan, D. L., Larner, J. M., & Dziegielewski, J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0485 · Cited by 64
Klumpp, D., Misovic, M., Szteyn, K., Shumilina, E. V., Rudner, J., & Huber, S. M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8026702 · Cited by 63
CRAC channels, calcium, and cancer in light of the driver and passenger concept
Hoth, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.009 · Cited by 55
Shen, L., Wen, N., Xia, M., ZHANG, Y., LIU, W., Xu, Y., & Sun, L. (2016) · Oncology Letters · doi:10.3892/ol.2016.4278 · Cited by 54
Park, H., Lee, J., Lim, J., & Kang, B. H. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-148 · Cited by 53
T-type Ca2+ Channels: T for Targetable
Sallan, M. C., Visa, A., Shaikh, S., Nàger, M., Herreros, J., & Cantí, C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3061 · Cited by 47
Zhang, S., Miao, Y., Zheng, X. F. S., Gong, Y. S., Zhang, J., Zou, F., & Cai, C. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.009 · Cited by 45
The voltage gated Ca2+-channel Cav3.2 and therapeutic responses in breast cancer
Pera, E., Kaemmerer, E., Milevskiy, M. J. G., Yapa, K. T. D. S., O’Donnell, J. S., Brown, M. A., Simpson, F., Peters, A. A., Roberts‐Thomson, S. J., & Monteith, G. R. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0299-0 · Cited by 45
Self-citationBoudreau, A., van't Veer, L. J., & Bissell, M. J. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20880 · Cited by 43
TRPM8 is required for survival and radioresistance of glioblastoma cells
Klumpp, D., Frank, S. C., Klumpp, L., Sezgın, E., Eckert, M., Edalat, L., Bastmeyer, M., Zips, D., Ruth, P., & Huber, S. M. (2017) · Oncotarget · doi:10.18632/oncotarget.21436 · Cited by 43
Günes, D. A., Florea, A.-M., Splettstoesser, F., & Büsselberg, D. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.12.001 · Cited by 42
Hegedüs, L., Garay, T., Molnár, E., Varga, K., Bilecz, Á., Török, S., Padányi, R., Pászty, K., Wolf, M., Grusch, M., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30503 · Cited by 39
Vacher, P., Vacher, A.-M., Pineau, R., Latour, S., Soubeyran, I., Pangault, C., Tarte, K., Soubeyran, P., Ducret, T., & Bresson‐Bepoldin, L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402942 · Cited by 32
Bassett, J. J., & Monteith, G. R. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.01.001 · Cited by 31
Self-citationAbdoul‐Azize, S., Dubus, I., & Vannier, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16039 · Cited by 23
Cited by
Integrative proteogenomic characterization of early esophageal cancer
Li, L., Jiang, D., Zhang, Q., Liu, H., Xu, F., Guo, C., Qin, Z., Wang, H., Feng, J., Liu, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37440-w · Cited by 67
Metadata
- Authors
- Bong, A. H. L., & Monteith, G. R.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 1865
- Issue
- 11
- Pages
- 1786-1794
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2804555736
- Cited by
- 178
- References
- 100
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.